67 / 100

Assoc Prof Dr. Teresa Vanessa Fiorentino | Medicina Interna | Best Researcher Award

Professor Associate at University of Magna Graecia of Catanzaro, Italy.

Teresa Vanessa Fiorentino is an accomplished Associate Professor in Internal Medicine at the University of Magna Græcia, Catanzaro, with an impressive career in academic research, focusing on diabetes and metabolic disorders. With international research experience and numerous publications in high-impact journals, Dr. Fiorentino has established herself as a leading figure in her field. She actively contributes to the academic and medical communities through her editorial roles, teaching, and participation in scientific societies.

Profile:

Education

Dr. Fiorentino earned her degree in Medicine and Surgery with honors (110/110 cum laude) in 2008 from the University of Magna Græcia in Catanzaro, Italy. She pursued specialization in Internal Medicine at the same institution, graduating with honors in 2014. During her education, she completed a prestigious post-doctoral fellowship at the University of Texas Health Science Center at San Antonio, gaining invaluable experience in diabetes research. In 2018, she also earned a PhD focusing on biomarkers for chronic and complex diseases.

Professional Experience

Dr. Fiorentino has held various academic and research positions throughout her career. From 2014 to 2018, she served as a PhD candidate and research fellow in Internal Medicine. In 2018, she became a fixed-term researcher and has been serving as an Associate Professor at the University of Magna Græcia since December 2021. She also holds clinical responsibilities at the University Hospital “Renato Dulbecco” in Catanzaro, specializing in Internal Medicine. Additionally, she has been a faculty member in multiple PhD programs and specializations.

Research Interest

Dr. Fiorentino’s research interests are primarily centered around metabolic diseases, particularly type 2 diabetes, insulin resistance, and glucose metabolism. She is also interested in investigating biomarkers for chronic and complex diseases and exploring how molecular and physiological factors contribute to these conditions. Her work emphasizes translational research aimed at improving the prediction, prevention, and treatment of chronic diseases.

Research Skills

Dr. Bushra Bashir’s research skills encompass a broad range of techniques essential for advanced organic chemistry. She is proficient in synthesis, chromatography, recrystallization, and extraction, which are crucial for developing and purifying chemical compounds. Her expertise extends to spectroscopic characterization and crystallography, providing detailed analysis of molecular structures. Additionally, Dr. Bashir is skilled in using research software such as Chemdraw, Mestrenova, IBM SPSS, Origin, and Endnote, which support data analysis and research documentation.

Award and Recognition

Dr. Fiorentino has received numerous accolades for her academic and research achievements. She has obtained two National Scientific Qualifications, first as an Associate Professor in 2017 and later as a Full Professor in 2022. She has held significant leadership roles in prestigious organizations such as the Italian Society of Diabetology and served on editorial boards for various prominent journals, further highlighting her expertise and contributions to the field.

Conclusion

Dr. Teresa Vanessa Fiorentino is a highly accomplished researcher with substantial contributions to internal medicine and diabetes research. Her academic and research background, coupled with her leadership roles in scientific societies, positions her as a strong candidate for the Best Researcher Award. Strengthening her profile through diversification of research and increased global collaborations could further elevate her standing, making her even more competitive in future award considerations.

Publication Top Notes

  • Compromised cardiac autonomic function in non-diabetic subjects with 1 h post-load hyperglycemia: a cross-sectional study
    Authors: Monea, G., Jiritano, R., Salerno, L., Fiorentino, T.V., Andreozzi, F.
    Year: 2024
    📄 Cardiovascular Diabetology, 23(1), 295
    Citations: 0
  • Association between augmented levels of the gut pro-hormone Proneurotensin and subclinical vascular damage
    Authors: De Vito, F., Fiorentino, T.V., Facciolo, A., Sesti, G., Andreozzi, F.
    Year: 2024
    📄 Scientific Reports, 14(1), 15086
    Citations: 0
  • Sex-specific differences in myocardial glucose metabolic rate in non-diabetic, pre-diabetic, and type 2 diabetic subjects
    Authors: Succurro, E., Vizza, P., Cicone, F., Cascini, G.L., Sesti, G.
    Year: 2024
    📄 Cardiovascular Diabetology, 23(1), 144
    Citations: 0
  • Mean platelet volume (MPV) as a new marker of diabetic macrovascular complications in patients with different glucose homeostasis: Platelets in cardiovascular risk
    Authors: Cassano, V., Armentaro, G., Iembo, D., Pujia, A., Sciacqua, A.
    Year: 2024
    📄 Cardiovascular Diabetology, 23(1), 89
    Citations: 3
  • GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes
    Authors: Ciardullo, S., Morieri, M.L., Daniele, G., Solini, A., Avogaro, A.
    Year: 2024
    📄 Acta Diabetologica, 61(8), pp. 941–950
    Citations: 0
  • Frequency of prediabetes in individuals with increased adiposity and metabolically healthy or unhealthy phenotypes
    Authors: Cefalo, C.M.A., Riccio, A., Succurro, E., Andreozzi, F., Sesti, G.
    Year: 2024
    📄 Diabetes, Obesity and Metabolism, 26(8), pp. 3191–3199
    Citations: 1
  • Glucagon-like peptide 1 receptor is a T cell-negative costimulatory molecule
    Authors: Ben Nasr, M., Usuelli, V., Dellepiane, S., Folli, F., Fiorina, P.
    Year: 2024
    📄 Cell Metabolism, 36(6), pp. 1302–1319.e12
    Citations: 3
  • Myocardial mechano-energetic efficiency is not impaired in patients with metabolically healthy overweight and obesity
    Authors: Cefalo, C.M.A., Riccio, A., Fiorentino, T.V., Andreozzi, F., Sesti, G.
    Year: 2024
    📄 Obesity, 32(5), pp. 888–899
    Citations: 0
  • Asymmetric dimethylarginine (ADMA) is associated with reduced myocardial mechano-energetic efficiency in hypertensive subjects
    Authors: Cefalo, C.M.A., Riccio, A., Fiorentino, T.V., Perticone, F., Sesti, G.
    Year: 2024
    📄 Nutrition, Metabolism and Cardiovascular Diseases, 34(5), pp. 1175–1178
    Citations: 0
  • Whole blood viscosity is associated with reduced myocardial mechano-energetic efficiency in non-diabetic individuals
    Authors: Riccio, A., Cefalo, C.M.A., Mazzanti, C., Andreozzi, F., Sesti, G.
    Year: 2024
    📄 European Journal of Clinical Investigation, 54(3), e14127
    Citations: 1
Teresa Vanessa Fiorentino | Medicina Interna | Best Researcher Award

You May Also Like